99% Savings - Buy Just @1 Rs X
Oncophos 1000 mg Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Ovarian Cancer, Multiple Myeloma. The alternative uses of Oncophos 1000 mg Injection have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Oncophos 1000 mg Injection. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Oncophos 1000 mg Injection side effects, there are can be others also. These have been listed below. These side effects of Oncophos 1000 mg Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Oncophos 1000 mg Injection's effect during pregnancy is Severe and Severe while nursing. Warnings related to Oncophos 1000 mg Injection's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Oncophos 1000 mg Injection contraindications section.
Drug interactions for Oncophos 1000 mg Injection have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Oncophos 1000 mg Injection is considered not safe while driving, and is not addictive.
Oncophos 1000 mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Adult |
|
Is the use of Oncophos 1000 mg Injection safe for pregnant women?
Oncophos can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Oncophos 1000 mg Injection safe during breastfeeding?
Oncophos may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Oncophos 1000 mg Injection on the Kidneys?
Oncophos may have mild side effects on the kidneys.
What is the effect of Oncophos 1000 mg Injection on the Liver?
Side effects of Oncophos rarely affect the liver.
What is the effect of Oncophos 1000 mg Injection on the Heart?
Oncophos has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Oncophos 1000 mg Injection unless your doctor advises you to do so -
Is this Oncophos 1000 mg Injection habit forming or addictive?
Oncophos 1000 mg Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Oncophos 1000 mg Injection. So it is best to avoid driving.
Is it safe?
Oncophos 1000 mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Oncophos 1000 mg Injection is unable to treat or cure mental disorders.
Interaction between Food and Oncophos 1000 mg Injection
Taking Oncophos 1000 mg Injection with food does not cause any problems.
Interaction between Alcohol and Oncophos 1000 mg Injection
It is difficult to say anything about the effect of Oncophos 1000 mg Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377